(Q38288478)

English

Multigene targeting of signal transduction pathways for the treatment of breast and prostate tumors: comparison between combination therapies employing bispecific oligonucleotides with either Rapamycin or Paclitaxel

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Multigene targeting of signal transduction pathways for the treatment of breast and prostate tumors: comparison between combination therapies employing bispecific oligonucleotides with either Rapamycin or Paclitaxel (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

1 reference

based on heuristic

inferred from title

author name string

Marvin Rubenstein

1

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Paulus Tsui

2

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Patrick Guinan

3

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

7 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

124-130

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Synthesis of branched antisense oligonucleotides having multiple specificities. Treatment of hormone insensitive prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-008-9088-5

21 January 2018

Ras, PI(3)K and mTOR signalling controls tumour cell growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/18686047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bispecific antisense oligonucleotides with multiple binding sites for the treatment of prostate tumors and their applicability to combination therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18686047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II study of biweekly paclitaxel and radiation in androgen-ablated locally advanced prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18686047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18686047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic effects of combination therapy employing antisense oligonucleotides with traditional chemotherapeutics in the PC-3 prostate cancer model

1 reference

https://pubmed.ncbi.nlm.nih.gov/18686047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model

1 reference

https://pubmed.ncbi.nlm.nih.gov/18686047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The mammalian target of the rapamycin (mTOR) kinase pathway: its role in tumourigenesis and targeted antitumour therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18686047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Construction of a bispecific antisense oligonucleotide containing multiple binding sites for the treatment of hormone insensitive prostate tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18686047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of MCF-7 breast cancer cells employing mono- and bispecific antisense oligonucleotides having binding specificity toward proteins associated with autocrine regulated growth and BCL-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18686047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18686047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

mTOR and cancer: insights into a complex relationship

1 reference

https://pubmed.ncbi.nlm.nih.gov/18686047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18686047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A retroinhibition approach reveals a tumor cell-autonomous response to rapamycin in head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18686047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy employing bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18686047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of PC-3 prostate cancer cell growth in vitro using both antisense oligonucleotides and taxol

1 reference

https://pubmed.ncbi.nlm.nih.gov/18686047

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-008-9088-5

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38288478&oldid=2201521425"